Follow-up and earlyoutcomes
With a median follow up of 6 months (2-14 months), 4 patients had
progressed (after a median time of 3 months) of which 3 patients
progressed in the irradiated volume whereas 1 child with refractory yolk
sac tumor progressed with lung metastases. Three of these patients are
undergoing salvage treatment whereas one patient remains controlled
after salvage surgery and chemotherapy. All other patients continue to
be on follow-up and have no clinical or radiological signs of
progression.